BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35604618)

  • 1. Cognitive phenotyping of post-infectious SARS-CoV-2 patients.
    Aiello EN; Radici A; Mora G; Pain D
    Neurol Sci; 2022 Aug; 43(8):4599-4604. PubMed ID: 35604618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).
    Aiello EN; Fiabane E; Manera MR; Radici A; Grossi F; Ottonello M; Pain D; Pistarini C
    Neurol Sci; 2022 Jan; 43(1):81-84. PubMed ID: 34668124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodic long-term memory in post-infectious SARS-CoV-2 patients.
    Aiello EN; Fiabane E; Manera MR; Radici A; Grossi F; Ottonello M; Vassallo C; Pain D; Pistarini C
    Neurol Sci; 2022 Feb; 43(2):785-788. PubMed ID: 34791568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.
    Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
    Stroke; 2012 Feb; 43(2):464-9. PubMed ID: 22156700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Assessment in SARS-CoV-2 Patients: A Systematic Review.
    Biagianti B; Di Liberto A; Nicolò Edoardo A; Lisi I; Nobilia L; de Ferrabonc GD; Zanier ER; Stocchetti N; Brambilla P
    Front Aging Neurosci; 2022; 14():909661. PubMed ID: 35847679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between objective cognitive measures and ecological-functional outcomes in COVID-19.
    Ottonello M; Fiabane E; Aiello EN; Manera MR; Spada F; Pistarini C
    Front Psychol; 2022; 13():903697. PubMed ID: 36389563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study.
    Diana L; Regazzoni R; Sozzi M; Piconi S; Borghesi L; Lazzaroni E; Basilico P; Aliprandi A; Bolognini N; Bonardi DR; Colombo D; Salmaggi A
    J Neurol Sci; 2023 Jan; 444():120511. PubMed ID: 36473347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Mini-Mental State Examination and Montreal Cognitive Assessment executive subtests in detecting post-stroke cognitive impairment.
    Fu C; Jin X; Chen B; Xue F; Niu H; Guo R; Chen Z; Zheng H; Wang L; Zhang Y
    Geriatr Gerontol Int; 2017 Dec; 17(12):2329-2335. PubMed ID: 28675607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients.
    Manera MR; Fiabane E; Pain D; Aiello EN; Radici A; Ottonello M; Padovani M; Wilson BA; Fish J; Pistarini C
    Neurol Sci; 2022 Jan; 43(1):45-50. PubMed ID: 34779965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
    Schild AK; Goereci Y; Scharfenberg D; Klein K; Lülling J; Meiberth D; Schweitzer F; Stürmer S; Zeyen P; Sahin D; Fink GR; Jessen F; Franke C; Onur OA; Kessler J; Warnke C; Maier F
    J Neurol; 2023 Mar; 270(3):1215-1223. PubMed ID: 36422669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity of the Addenbrooke's Cognitive Examination-Revised (ACE-R) in acute stroke.
    Morris K; Hacker V; Lincoln NB
    Disabil Rehabil; 2012; 34(3):189-95. PubMed ID: 21954948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spanish version of the Addenbrooke's Cognitive Examination - Revised (ACE-R) in subcortical ischemic vascular dementia.
    Raimondi C; Gleichgerrcht E; Richly P; Torralva T; Roca M; Camino J; Manes F
    J Neurol Sci; 2012 Nov; 322(1-2):228-31. PubMed ID: 22959102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The COgnitiVID study.
    Vialatte de Pémille C; Ray A; Michel A; Stefano F; Yim T; Bruel C; Zuber M
    Rev Neurol (Paris); 2022 Oct; 178(8):802-807. PubMed ID: 35610098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort.
    Voruz P; Jacot de Alcântara I; Nuber-Champier A; Cionca A; Allali G; Benzakour L; Lalive PH; Lövblad KO; Braillard O; Nehme M; Coen M; Serratrice J; Reny JL; Pugin J; Guessous I; Ptak R; Landis BN; Assal F; Péron JA
    Arch Clin Neuropsychol; 2023 Jan; 38(1):1-11. PubMed ID: 35942646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.
    Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive consequences of COVID-19: results of a cohort study from South America.
    Crivelli L; Calandri I; Corvalán N; Carello MA; Keller G; Martínez C; Arruabarrena M; Allegri R
    Arq Neuropsiquiatr; 2022 Mar; 80(3):240-247. PubMed ID: 34816972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Cuban Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Cognitive Impairment.
    Broche-Pérez Y; López-Pujol HA
    Dement Geriatr Cogn Disord; 2017; 44(5-6):320-327. PubMed ID: 29393151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease.
    Cohen OS; Vakil E; Tanne D; Molshatzki N; Nitsan Z; Hassin-Baer S
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):71-7. PubMed ID: 22689698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.